Skip to main content
SpringerLink
Log in

The Function of SPARC in Tumor Cell Biology: SPARC as a Modulator of Cell–Extracellular Matrix Interaction

  • Chapter
  • First Online:
Cell-Extracellular Matrix Interactions in Cancer

  • 1255 Accesses

Abstract

Although alterations in the level of SPARC (secreted protein, acidic and rich in cysteine; also known as osteonectin) expression have been associated with a large number of studies on tumor tissue from various anatomical locations, the mechanisms by which SPARC influences tumor progression are not well defined. The capacity of SPARC to affect cellular proliferation, adhesion, migration, and invasion in a cell and tissue-specific manner further complicates the analysis of the function of SPARC in tumor biology. In this chapter, an effort is made to bring together results generated from a number of different studies that highlight functional consequences of SPARC expression. Emphasis has been placed on cell–extracellular matrix interactions, in particular collagen-binding and collagen receptor activity. Likely, it is the contextual nature of divergent functions associated with SPARC, based in unique tissue microenvironments, that give rise to what are seen as seemingly contradictory effects of SPARC expression in different tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agarwal G, Kovac L, Radziejewski C, Samuelsson SJ (2002) Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation. Biochemistry 41:11091–11098

    Article  CAS  PubMed  Google Scholar 

  • Alvarez MJ, Prada F, Salvatierra E, Bravo AI, Lutzky VP, Carbone C, Pitossi FJ, Chuluyan HE, Podhajcer OL (2005) Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res 65:5123–5132

    Article  CAS  PubMed  Google Scholar 

  • Arnold SA, Mira E, Muneer S, Korpanty G, Beck AW, Holloway SE, Manes S, Brekken RA (2008) Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med (Maywood) 233(7):860–873

    Article  CAS  Google Scholar 

  • Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280:36483–36493

    Article  CAS  PubMed  Google Scholar 

  • Bassuk JA, Iruela-Arispe ML, Lane TF, Benson JM, Berg RA, Sage EH (1993) Molecular analysis of chicken embryo SPARC (osteonectin). Eur J Biochem 218:117–127

    Article  CAS  PubMed  Google Scholar 

  • Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608–616

    Article  CAS  PubMed  Google Scholar 

  • Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049–1054

    Article  CAS  PubMed  Google Scholar 

  • Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH (2001) Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen 9:522–530

    Article  CAS  PubMed  Google Scholar 

  • Bradshaw AD, Reed MJ, Sage EH (2002) SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50:1–10

    CAS  PubMed  Google Scholar 

  • Bradshaw AD, Graves DC, Motamed K, Sage EH (2003a) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci U S A 100:6045–6050

    Article  CAS  PubMed  Google Scholar 

  • Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Sage EH (2003b) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120:949–955

    Article  CAS  PubMed  Google Scholar 

  • Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19:816–827

    Article  CAS  PubMed  Google Scholar 

  • Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH (2003) Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 111:487–495

    CAS  PubMed  Google Scholar 

  • Chlenski A, Liu S, Baker LJ, Yang Q, Tian Y, Salwen HR, Cohn SL (2004) Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC. Cancer Res 64:7420–7425

    Article  CAS  PubMed  Google Scholar 

  • Clark CJ, Sage EH (2008) A prototypic matricellular protein in the tumor microenvironment–where there’s SPARC, there’s fire. J Cell Biochem 104:721–732

    Article  CAS  PubMed  Google Scholar 

  • Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729–743

    Article  CAS  PubMed  Google Scholar 

  • De S, Chen J, Narizhneva NV, Heston W, Brainard J, Sage EH, Byzova TV (2003) Molecular pathway for cancer metastasis to bone. J Biol Chem 278:39044–39050

    Article  CAS  PubMed  Google Scholar 

  • Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E (2003) Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology 144:2588–2596

    Article  CAS  PubMed  Google Scholar 

  • Emerson RO, Sage EH, Ghosh JG, Clark JI (2006) Chaperone-like activity revealed in the matricellular protein SPARC. J Cell Biochem 98:701–705

    Article  CAS  PubMed  Google Scholar 

  • Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE (2000) Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol 151:779–788

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald MC, Schwarzbauer JE (1998) Importance of the basement membrane protein SPARC for viability and fertility in Caenorhabditis elegans. Curr Biol 8:1285–1288

    Article  CAS  PubMed  Google Scholar 

  • Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92:679–690

    Article  CAS  PubMed  Google Scholar 

  • Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH (1999) SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem 274:32145–32152

    Article  CAS  PubMed  Google Scholar 

  • Francki A, McClure TD, Brekken RA, Motamed K, Murri C, Wang T, Sage EH (2004) SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem 91:915–925

    Article  CAS  PubMed  Google Scholar 

  • Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, Sage EH, Zern MA (1995) Expression of SPARC in normal and fibrotic livers. Hepatology 21:847–854

    CAS  PubMed  Google Scholar 

  • Funk SE, Sage EH (1991) The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci U S A 88:2648–2652

    Article  CAS  PubMed  Google Scholar 

  • Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, Hogan BL, Evans MJ, Colledge WH (1998) Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 17:1860–1870

    Article  CAS  PubMed  Google Scholar 

  • Giudici C, Raynal N, Wiedemann H, Cabral WA, Marini JC, Timpl R, Bachinger HP, Farndale RW, Sasaki T, Tenni R (2008) Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. J Biol Chem 283(28):19551–19560

    Article  CAS  PubMed  Google Scholar 

  • Golembieski WA, Thomas SL, Schultz CR, Yunker CK, McClung HM, Lemke N, Cazacu S, Barker T, Sage EH, Brodie C, Rempel SA (2008) HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion. Glia 56:1061–1075

    Article  PubMed  Google Scholar 

  • Haber CL, Gottifredi V, Llera AS, Salvatierra E, Prada F, Alonso L, Sage EH, Podhajcer OL (2008) SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. Int J Cancer 122:1465–1475

    Article  CAS  PubMed  Google Scholar 

  • Hasselaar P, Sage EH (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49:272–283

    Article  CAS  PubMed  Google Scholar 

  • Hohenadl C, Mann K, Mayer U, Timpl R, Paulsson M, Aeschlimann D (1995) Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification. J Biol Chem 270:23415–23420

    Article  CAS  PubMed  Google Scholar 

  • Hohenester E, Maurer P, Hohenadl C, Timpl R, Jansonius JN, Engel J (1996) Structure of a novel extracellular Ca(2+)-binding module in BM-40. Nat Struct Biol 3:67–73

    Article  CAS  PubMed  Google Scholar 

  • Hohenester E, Maurer P, Timpl R (1997) Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. EMBO J 16:3778–3786

    Article  CAS  PubMed  Google Scholar 

  • Hughes RC, Taylor A, Sage H, Hogan BL (1987) Distinct patterns of glycosylation of colligin, a collagen-binding glycoprotein, and SPARC (osteonectin), a secreted Ca2+-binding glycoprotein. Evidence for the localisation of colligin in the endoplasmic reticulum. Eur J Biochem 163:57–65

    Article  CAS  PubMed  Google Scholar 

  • Kaufmann B, Muller S, Hanisch FG, Hartmann U, Paulsson M, Maurer P, Zaucke F (2004) Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity. Glycobiology 14:609–619

    Article  CAS  PubMed  Google Scholar 

  • Kelly KA, Allport JR, Yu AM, Sinh S, Sage EH, Gerszten RE, Weissleder R (2007) SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J Leukoc Biol 81:748–756

    Article  CAS  PubMed  Google Scholar 

  • Kelm RJ Jr, Mann KG (1991) The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J Biol Chem 266:9632–9639

    CAS  PubMed  Google Scholar 

  • Konitsiotis AD, Raynal N, Bihan D, Hohenester E, Farndale RW, Leitinger B (2008) Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem 283:6861–6868

    Article  CAS  PubMed  Google Scholar 

  • Kupprion C, Motamed K, Sage EH (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273:29635–29640

    Article  CAS  PubMed  Google Scholar 

  • Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, Gratchev A, Krusell L, Goerdt S, Sage EH (2006) Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 176:5825–5832

    CAS  PubMed  Google Scholar 

  • Lane TF, Sage EH (1990) Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape. J Cell Biol 111:3065–3076

    Article  CAS  PubMed  Google Scholar 

  • Lee H, Overall CM, McCulloch CA, Sodek J (2006) A critical role for MT1-MMP in collagen phagocytosis. Mol Biol Cell 17(11):4812–4826

    Article  CAS  PubMed  Google Scholar 

  • Liu P, Lu J, Cardoso WV, Vaziri C (2008) The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol Biol Cell 19:248–261

    Article  CAS  PubMed  Google Scholar 

  • Martinek N, Zou R, Berg M, Sodek J, Ringuette M (2002) Evolutionary conservation and association of SPARC with the basal lamina in Drosophila. Dev Genes Evol 212:124–133

    Article  CAS  PubMed  Google Scholar 

  • Martinek N, Shahab J, Sodek J, Ringuette M (2007) Is SPARC an evolutionarily conserved collagen chaperone? J Dent Res 86:296–305

    Article  CAS  PubMed  Google Scholar 

  • Martinek N, Shahab J, Saathoff M, Ringuette M (2008) Haemocyte-derived SPARC is required for collagen-IV-dependent stability of basal laminae in Drosophila embryos. J Cell Sci 121:1671–1680

    Article  CAS  PubMed  Google Scholar 

  • Mason IJ, Taylor A, Williams JG, Sage H, Hogan BL (1986) Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43, 000. EMBO J 5:1465–1472

    CAS  PubMed  Google Scholar 

  • Maurer P, Mayer U, Bruch M, Jeno P, Mann K, Landwehr R, Engel J, Timpl R (1992) High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur J Biochem 205:233–240

    Article  CAS  PubMed  Google Scholar 

  • Mayer U, Aumailley M, Mann K, Timpl R, Engel J (1991) Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem 198:141–150

    Article  CAS  PubMed  Google Scholar 

  • McCulloch CA (2004) Drug-induced fibrosis: interference with the intracellular collagen degradation pathway. Curr Opin Drug Discov Devel 7:720–724

    CAS  PubMed  Google Scholar 

  • Norose K, Clark JI, Syed NA, Basu A, Heber-Katz E, Sage EH, Howe CC (1998) SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci 39:2674–2680

    CAS  PubMed  Google Scholar 

  • Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J (2006) Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest 116:422–429

    Article  CAS  PubMed  Google Scholar 

  • Orr AW, Ginsberg MH, Shattil SJ, Deckmyn H, Schwartz MA (2006) Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell 17:4686–4697

    Article  CAS  PubMed  Google Scholar 

  • Pan MR, Chang HC, Chuang LY, Hung WC (2008) The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells. Exp Biol Med (Maywood) 233:456–462

    Article  CAS  Google Scholar 

  • Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG (1996) SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50:1978–1989

    Article  CAS  PubMed  Google Scholar 

  • Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E, Llera AS (2008) Cancer Metastasis Rev 27:691–705

    Google Scholar 

  • Prada F, Benedetti LG, Bravo AI, Alvarez MJ, Carbone C, Podhajcer OL (2007) SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol 127:2618–2628

    Article  CAS  PubMed  Google Scholar 

  • Puolakkainen P, Bradshaw AD, Kyriakides TR, Reed M, Brekken R, Wight T, Bornstein P, Ratner B, Sage EH (2003) Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol 162:627–635

    CAS  PubMed  Google Scholar 

  • Puolakkainen PA, Brekken RA, Muneer S, Sage EH (2004) Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res 2:215–224

    CAS  PubMed  Google Scholar 

  • Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 89:1281–1285

    Article  CAS  PubMed  Google Scholar 

  • Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH (1993) Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41:1467–1477

    CAS  PubMed  Google Scholar 

  • Rempel SA, Ge S, Gutierrez JA (1999) SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5:237–241

    CAS  PubMed  Google Scholar 

  • Rempel SA, Hawley RC, Gutierrez JA, Mouzon E, Bobbitt KR, Lemke N, Schultz CR, Schultz LR, Golembieski W, Koblinski J, VanOsdol S, Miller CG (2007) Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. Genes Immun 8:262–274

    Article  CAS  PubMed  Google Scholar 

  • Rentz TJ, Poobalarahi F, Bornstein P, Sage EH, Bradshaw AD (2007) SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem 282:22062–22071

    Article  CAS  PubMed  Google Scholar 

  • Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E, Sabatie E, Cano A, Garcia de Herreros A, Ballotti R, Tartare-Deckert S (2006) SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 66:7516–7523

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Jimenez FJ, Caldes T, Iniesta P, Vidart JA, Garcia-Asenjo JL, Benito M (2007) Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma. Oncol Rep 17:1301–1307

    CAS  PubMed  Google Scholar 

  • Roll S, Seul J, Paulsson M, Hartmann U (2006) Testican-1 is dispensable for mouse development. Matrix Biol 25:373–381

    Article  PubMed  CAS  Google Scholar 

  • Rotllant J, Liu D, Yan YL, Postlethwait JH, Westerfield M, Du SJ (2008) Sparc (Osteonectin) functions in morphogenesis of the pharyngeal skeleton and inner ear. Matrix Biol 27(6):561–572

    Article  CAS  PubMed  Google Scholar 

  • Said N, Motamed K (2005) Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. Am J Pathol 167:1739–1752

    CAS  PubMed  Google Scholar 

  • Said N, Socha MJ, Olearczyk JJ, Elmarakby AA, Imig JD, Motamed K (2007) Normalization of the ovarian cancer microenvironment by SPARC. Mol Cancer Res 5:1015–1030

    Article  CAS  PubMed  Google Scholar 

  • Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP (2003) Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med 198:1475–1485

    Article  CAS  PubMed  Google Scholar 

  • Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A, Chiodoni C, Colombo MP (2005) Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci 118:3685–3694

    Article  CAS  PubMed  Google Scholar 

  • Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knauper V, Murphy G, Timpl R (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237–9243

    Article  CAS  PubMed  Google Scholar 

  • Sasaki T, Hohenester E, Gohring W, Timpl R (1998) Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J 17:1625–1634

    Article  CAS  PubMed  Google Scholar 

  • Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M (2003) SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 22:5021–5030

    Article  CAS  PubMed  Google Scholar 

  • Schiemann BJ, Neil JR, Schiemann WP (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell 14:3977–3988

    Article  CAS  PubMed  Google Scholar 

  • Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA (2002) Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 62:6270–6277

    CAS  PubMed  Google Scholar 

  • Schwarzbauer JE, Spencer CS (1993) The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility. Mol Biol Cell 4:941–952

    CAS  PubMed  Google Scholar 

  • Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN (2007) Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26:4084–4094

    Article  CAS  PubMed  Google Scholar 

  • Soderling JA, Reed MJ, Corsa A, Sage EH (1997) Cloning and expression of murine SC1, a gene product homologous to SPARC. J Histochem Cytochem 45:823–835

    CAS  PubMed  Google Scholar 

  • Sosa MS, Girotti MR, Salvatierra E, Prada F, de Olmo JA, Gallango SJ, Albar JP, Podhajcer OL, Llera AS (2007) Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. Proteomics 7:4123–4134

    Article  CAS  PubMed  Google Scholar 

  • Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15:114–123

    Article  CAS  PubMed  Google Scholar 

  • Strandjord TP, Madtes DK, Weiss DJ, Sage EH (1999) Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. Am J Physiol 277:L628–L635

    CAS  PubMed  Google Scholar 

  • Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana UG, Iizasa T, Fujisawa T, Hiroshima K, Gazdar AF (2005) Aberrant methylation of SPARC in human lung cancers. Br J Cancer 92:942–948

    Article  CAS  PubMed  Google Scholar 

  • Takeda U, Utani A, Wu J, Adachi E, Koseki H, Taniguchi M, Matsumoto T, Ohashi T, Sato M, Shinkai H (2002) Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J Invest Dermatol 119:678–683

    Article  CAS  PubMed  Google Scholar 

  • Tanaka S, Nambu F, Nambu Z (2001) Isolation of a cDNA encoding a putative SPARC from the brine shrimp, Artemia franciscana. Gene 268:53–58

    Article  CAS  PubMed  Google Scholar 

  • Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE (2003) Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14:968–980

    Article  CAS  PubMed  Google Scholar 

  • Tasab M, Batten MR, Bulleid NJ (2000) Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen. EMBO J 19:2204–2211

    Article  CAS  PubMed  Google Scholar 

  • Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M (2008) Fibronectin-TG2 matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta 1 integrin co-signaling. J Biol Chem 283(30):20937–20947

    Article  CAS  PubMed  Google Scholar 

  • Truty MJ, Urrutia R (2007) Basics of TGF-beta and pancreatic cancer. Pancreatology 7:423–435

    Article  CAS  PubMed  Google Scholar 

  • Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S (2002) Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 277:37377–37381

    Article  CAS  PubMed  Google Scholar 

  • Wang H, Fertala A, Ratner BD, Sage EH, Jiang S (2005a) Identifying the SPARC binding sites on collagen I and procollagen I by atomic force microscopy. Anal Chem 77:6765–6771

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, Adamson E, Mercola D, McClelland M (2005b) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7:748–760

    Article  CAS  PubMed  Google Scholar 

  • Weaver MS, Sage EH, Yan Q (2006) Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro. J Cell Biochem 97:423–432

    Article  CAS  PubMed  Google Scholar 

  • Weaver MS, Workman GA, Sage EH (2008) The copper-binding domain of sparc mediates cell survival in vitro via interaction with integrin beta 1 and activation of integrin-linked kinase. J Biol Chem 283(33):22826–22837

    Article  CAS  PubMed  Google Scholar 

  • White DJ, Puranen S, Johnson MS, Heino J (2004) The collagen receptor subfamily of the integrins. Int J Biochem Cell Biol 36:1405–1410

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Gurusiddappa S, Rich RL, Owens RT, Keene DR, Mayne R, Hook A, Hook M (2000) Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. J Biol Chem 275:38981–38989

    Article  CAS  PubMed  Google Scholar 

  • Yan Q, Clark JI, Wight TN, Sage EH (2002) Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. J Cell Sci 115:2747–2756

    CAS  PubMed  Google Scholar 

  • Yan Q, Blake D, Clark JI, Sage EH (2003) Expression of the matricellular protein SPARC in murine lens: SPARC is necessary for the structural integrity of the capsular basement membrane. J Histochem Cytochem 51:503–511

    CAS  PubMed  Google Scholar 

  • Yang E, Kang HJ, Koh KH, Rhee H, Kim NK, Kim H (2007) Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer 121:567–575

    Article  CAS  PubMed  Google Scholar 

  • Yunker CK, Golembieski W, Lemke N, Schultz CR, Cazacu S, Brodie C, Rempel SA (2008) SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer 122:2735–2743

    Article  CAS  PubMed  Google Scholar 

  • Zhang WM, Kapyla J, Puranen JS, Knight CG, Tiger CF, Pentikainen OT, Johnson MS, Farndale RW, Heino J, Gullberg D (2003) alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens. J Biol Chem 278:7270–7277

    Article  CAS  PubMed  Google Scholar 

  • Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD, Milewicz DM, Chakraborty R, Arnett FC (2003) Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum 48:2585–2592

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA

    Amy D. Bradshaw

  2. Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, UT-Southwestern Medical Center, Dallas, TX, 75390, USA

    Rolf A. Brekken

Authors
  1. Rolf A. Brekken
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy D. Bradshaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amy D. Bradshaw .

Editor information

Editors and Affiliations

  1. Vanderbilt University Medical Center, Department of Medicine, Nashville, 37232, U.S.A.

    Roy Zent

  2. Medical Center, Vanderbilt University, Nashville, 37232, U.S.A.

    Ambra Pozzi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Brekken, R.A., Bradshaw, A.D. (2010). The Function of SPARC in Tumor Cell Biology: SPARC as a Modulator of Cell–Extracellular Matrix Interaction. In: Zent, R., Pozzi, A. (eds) Cell-Extracellular Matrix Interactions in Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0814-8_8

Download citation

Publish with us

Policies and ethics

Search

Navigation